• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义核受体 PPARγ 中具有不同功能和结构的抑制状态。

Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ.

机构信息

Department of Biomedical and Pharmaceutical Sciences, University of Montana, 32 Campus Drive, Missoula, MT, 59812, USA.

Center for Biomolecular Structure and Dynamics, University of Montana, 32 Campus Drive, Missoula, MT, 59812, USA.

出版信息

Nat Commun. 2019 Dec 20;10(1):5825. doi: 10.1038/s41467-019-13768-0.

DOI:10.1038/s41467-019-13768-0
PMID:31862968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6925260/
Abstract

The repressive states of nuclear receptors (i.e., apo or bound to antagonists or inverse agonists) are poorly defined, despite the fact that nuclear receptors are a major drug target. Most ligand bound structures of nuclear receptors, including peroxisome proliferator-activated receptor γ (PPARγ), are similar to the apo structure. Here we use NMR, accelerated molecular dynamics and hydrogen-deuterium exchange mass spectrometry to define the PPARγ structural ensemble. We find that the helix 3 charge clamp positioning varies widely in apo and is stabilized by efficacious ligand binding. We also reveal a previously undescribed mechanism for inverse agonism involving an omega loop to helix switch which induces disruption of a tripartite salt-bridge network. We demonstrate that ligand binding can induce multiple structurally distinct repressive states. One state recruits peptides from two different corepressors, while another recruits just one, providing structural evidence of ligand bias in a nuclear receptor.

摘要

核受体的抑制状态(即无配体结合或与拮抗剂或反向激动剂结合)定义不明确,尽管核受体是主要的药物靶点。大多数核受体的配体结合结构,包括过氧化物酶体增殖物激活受体γ(PPARγ),与无配体结合结构相似。在这里,我们使用 NMR、加速分子动力学和氢氘交换质谱来定义 PPARγ 的结构集合。我们发现,无配体结合时,螺旋 3 电荷夹的定位变化很大,而有效配体结合则稳定了它的位置。我们还揭示了一种以前未被描述的反向激动机制,涉及 ω 环到螺旋的转换,这会导致三部分盐桥网络的破坏。我们证明,配体结合可以诱导多种结构上不同的抑制状态。一种状态从两个不同的共抑制因子招募肽,而另一种状态只招募一个,为核受体中的配体偏向提供了结构证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/039fc788c7b0/41467_2019_13768_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/c70bbd4c09f8/41467_2019_13768_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/e411db3fe1a5/41467_2019_13768_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/ca526cd4070b/41467_2019_13768_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/60b5bf9555cc/41467_2019_13768_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/5453dfd2c67b/41467_2019_13768_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/ff2dd63cbca4/41467_2019_13768_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/039fc788c7b0/41467_2019_13768_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/c70bbd4c09f8/41467_2019_13768_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/e411db3fe1a5/41467_2019_13768_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/ca526cd4070b/41467_2019_13768_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/60b5bf9555cc/41467_2019_13768_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/5453dfd2c67b/41467_2019_13768_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/ff2dd63cbca4/41467_2019_13768_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a4/6925260/039fc788c7b0/41467_2019_13768_Fig7_HTML.jpg

相似文献

1
Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ.定义核受体 PPARγ 中具有不同功能和结构的抑制状态。
Nat Commun. 2019 Dec 20;10(1):5825. doi: 10.1038/s41467-019-13768-0.
2
A structural mechanism for directing corepressor-selective inverse agonism of PPARγ.一种靶向 PPARγ 核心抑制剂选择性反向激动剂的结构机制。
Nat Commun. 2018 Nov 8;9(1):4687. doi: 10.1038/s41467-018-07133-w.
3
A molecular switch regulating transcriptional repression and activation of PPARγ.一种调控 PPARγ 转录抑制和激活的分子开关。
Nat Commun. 2020 Feb 19;11(1):956. doi: 10.1038/s41467-020-14750-x.
4
Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.在各种调节剂存在的情况下,过氧化物酶体增殖物激活受体γ配体结合域的氢/氘交换(H/D-Ex)
Protein Sci. 2006 Aug;15(8):1883-92. doi: 10.1110/ps.062103006. Epub 2006 Jul 5.
5
Defining a conformational ensemble that directs activation of PPARγ.定义一个构象集合,指导 PPARγ 的激活。
Nat Commun. 2018 May 4;9(1):1794. doi: 10.1038/s41467-018-04176-x.
6
Modification of the Orthosteric PPARγ Covalent Antagonist Scaffold Yields an Improved Dual-Site Allosteric Inhibitor.正构PPARγ共价拮抗剂支架的修饰产生了一种改进的双位点变构抑制剂。
ACS Chem Biol. 2017 Apr 21;12(4):969-978. doi: 10.1021/acschembio.6b01015. Epub 2017 Feb 16.
7
Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism.配体和受体动力学有助于解释 PPARγ 激动作用的递呈梯度机制。
Structure. 2012 Jan 11;20(1):139-50. doi: 10.1016/j.str.2011.10.018.
8
A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.一种过氧化物酶体增殖物激活受体γ拮抗剂可诱导波形蛋白裂解并抑制高级别肝细胞癌的侵袭。
Oncol Rep. 2007 Oct;18(4):825-32.
9
Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism.化学交联质谱揭示了 PPARγ 激活螺旋的构象景观;配体依赖性拮抗作用的模型。
Structure. 2018 Nov 6;26(11):1431-1439.e6. doi: 10.1016/j.str.2018.07.007. Epub 2018 Aug 23.
10
Insights into Dynamic Mechanism of Ligand Binding to Peroxisome Proliferator-Activated Receptor γ toward Potential Pharmacological Applications.对配体与过氧化物酶体增殖物激活受体 γ 结合的动态机制的深入了解,有助于潜在的药理学应用。
Biol Pharm Bull. 2021;44(9):1185-1195. doi: 10.1248/bpb.b21-00263.

引用本文的文献

1
Intensity, Duration, and Context Dependency of the Responses to Nutrient Surplus and Deprivation Signaling in the Heart: Insights Into the Complexities of Cardioprotection.心脏对营养过剩和营养缺乏信号反应的强度、持续时间及背景依赖性:对心脏保护复杂性的见解
Circulation. 2025 Sep 16;152(11):802-835. doi: 10.1161/CIRCULATIONAHA.125.075568. Epub 2025 Sep 15.
2
Predicting peroxisome proliferator-activated receptor gamma potency of small molecules: a synergistic consensus model and deep learning binding affinity approach powered by Enalos Cloud Platform.预测小分子的过氧化物酶体增殖物激活受体γ活性:一种由Enalos云平台驱动的协同共识模型和深度学习结合亲和力方法
Mol Divers. 2025 Jun 14. doi: 10.1007/s11030-025-11230-6.
3

本文引用的文献

1
The glucocorticoid receptor agonistic modulators CpdX and CpdX-D3 do not generate the debilitating effects of synthetic glucocorticoids.糖皮质激素受体激动调节剂 CpdX 和 CpdX-D3 不会产生合成糖皮质激素的衰弱作用。
Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):14200-14209. doi: 10.1073/pnas.1908264116. Epub 2019 Jun 20.
2
A revisited version of the apo structure of the ligand-binding domain of the human nuclear receptor retinoic X receptor α.人核受体视黄酸X受体α配体结合域脱辅基结构的修订版。
Acta Crystallogr F Struct Biol Commun. 2019 Feb 1;75(Pt 2):98-104. doi: 10.1107/S2053230X18018022. Epub 2019 Jan 23.
3
From Apo to Ligand-Bound: Unraveling PPARγ-LBD Conformational Shifts via Advanced Molecular Dynamics.
从脱辅基状态到配体结合状态:通过高级分子动力学解析PPARγ配体结合域的构象转变
ACS Omega. 2025 Feb 17;10(13):13303-13318. doi: 10.1021/acsomega.4c11128. eCollection 2025 Apr 8.
4
Ligand efficacy shifts a nuclear receptor conformational ensemble between transcriptionally active and repressive states.配体效力使核受体构象集合在转录活性状态和抑制状态之间转变。
Nat Commun. 2025 Feb 28;16(1):2065. doi: 10.1038/s41467-025-57325-4.
5
An abundant ginger compound furanodienone alleviates gut inflammation via the xenobiotic nuclear receptor PXR in mice.一种丰富的生姜化合物呋喃二烯酮通过小鼠体内的外源性核受体PXR减轻肠道炎症。
Nat Commun. 2025 Feb 3;16(1):1280. doi: 10.1038/s41467-025-56624-0.
6
Agonists of the Nuclear Receptor PPARγ Can Produce Biased Signaling.核受体 PPARγ 的激动剂可产生偏向性信号。
Mol Pharmacol. 2024 Nov 18;106(6):309-318. doi: 10.1124/molpharm.124.000992.
7
Oxidative Stress and the Nrf2/PPARγ Axis in the Endometrium: Insights into Female Fertility.氧化应激与子宫内膜中的 Nrf2/PPARγ 轴:对女性生育能力的启示。
Cells. 2024 Jun 22;13(13):1081. doi: 10.3390/cells13131081.
8
PPARγ Antagonists Exhibit Antitumor Effects by Regulating Ferroptosis and Disulfidptosis.过氧化物酶体增殖物激活受体 γ 拮抗剂通过调控铁死亡和二硫化物死亡发挥抗肿瘤作用。
Biomolecules. 2024 May 18;14(5):596. doi: 10.3390/biom14050596.
9
Ligand efficacy shifts a nuclear receptor conformational ensemble between transcriptionally active and repressive states.配体效力使核受体构象集合在转录活性状态和抑制状态之间转变。
bioRxiv. 2024 Apr 24:2024.04.23.590805. doi: 10.1101/2024.04.23.590805.
10
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.国际基础与临床药理学联盟第十三分会:核受体超家族-2023 更新。
Pharmacol Rev. 2023 Nov;75(6):1233-1318. doi: 10.1124/pharmrev.121.000436. Epub 2023 Aug 16.
Assessment of GAFF2 and OPLS-AA General Force Fields in Combination with the Water Models TIP3P, SPCE, and OPC3 for the Solvation Free Energy of Druglike Organic Molecules.
评估 GAFF2 和 OPLS-AA 通用力场与 TIP3P、SPCE 和 OPC3 水模型相结合,用于计算类药物有机分子的溶剂化自由能。
J Chem Theory Comput. 2019 Mar 12;15(3):1983-1995. doi: 10.1021/acs.jctc.8b01039. Epub 2019 Feb 14.
4
A structural mechanism for directing corepressor-selective inverse agonism of PPARγ.一种靶向 PPARγ 核心抑制剂选择性反向激动剂的结构机制。
Nat Commun. 2018 Nov 8;9(1):4687. doi: 10.1038/s41467-018-07133-w.
5
PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix.与拮抗剂和反向激动剂结合的PPARγ:激活螺旋的翻转和捕获机制
iScience. 2018 Feb 27;5:69-79. doi: 10.1016/j.isci.2018.06.012. Epub 2018 Jul 2.
6
The nuclear receptor superfamily: A structural perspective.核受体超家族:结构视角。
Protein Sci. 2018 Nov;27(11):1876-1892. doi: 10.1002/pro.3496.
7
Defining a conformational ensemble that directs activation of PPARγ.定义一个构象集合,指导 PPARγ 的激活。
Nat Commun. 2018 May 4;9(1):1794. doi: 10.1038/s41467-018-04176-x.
8
Biased signalling: from simple switches to allosteric microprocessors.偏向信号传导:从简单的开关到别构微处理器。
Nat Rev Drug Discov. 2018 Apr;17(4):243-260. doi: 10.1038/nrd.2017.229. Epub 2018 Jan 5.
9
Unique Interactome Network Signatures for Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Modulation by Functional Selective Ligands.功能性选择性配体对过氧化物酶体增殖物激活受体γ(PPARγ)调节的独特相互作用网络特征。
Mol Cell Proteomics. 2017 Dec;16(12):2098-2110. doi: 10.1074/mcp.RA117.000308. Epub 2017 Sep 29.
10
Structural review of PPARγ in complex with ligands: Cartesian- and dihedral angle principal component analyses of X-ray crystallographic data.过氧化物酶体增殖物激活受体γ(PPARγ)与配体复合物的结构综述:X射线晶体学数据的笛卡尔坐标和二面角主成分分析
Proteins. 2017 Sep;85(9):1684-1698. doi: 10.1002/prot.25325. Epub 2017 Jun 23.